Immunex Corporation records, 1983-2002.

  1. Resources
  2. View Resource

ArchivalResource

Immunex Corporation records, 1983-2002.

http://www.worldcat.org/oclc/83600910

Annual reports, news clippings, and other materials documenting biotechnology company Immunex from its founding in 1981 to its 2001 acquisition by Amgen.

4 boxes (2.5 linear ft.)

Museum of History and Industry

Information

SNAC Resource ID: 8304364

Related Entities

There are 1 Entities related to this resource.

Immunex (Firm)

http://n2t.net/ark:/99166/w6837z85 (corporateBody)

Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was the largest biotechnology ...